News

A new study suggests the Asthma Predictive Index can be used as a simple, noninvasive tool for determining asthma in preschoolers.

A new multi-year study shows that the immunotherapy increases tolerance of peanut products in patients with allergies.

IBD patients were less likely to have diets that regularly include vegetables, cereals, breads, and diary.

Sharon Hrynkow, PhD, joins the Rare Disease Report to discuss the ultra rare and heterogenous lysosomal storage disorder.

The cumulative time to curative treatment failure rates of patients who received DAA were 93.6% and 73.2% at 1 and 3 years, respectively.

Improving health literacy among these individuals may have a significant and positive impact on the transition from pediatric to adult care.

Kelly Chin, MD discusses the recent FDA approval of selexipag IV and breakthroughs in the cardiovascular care space.

The platform leverages optical coherence tomography and Ultreon Software.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

Italy and the Netherlands both achieved their target HBV control.

Infants between 6-12 months old had the highest prevalence of C difficile detection.

The first-in-class monoclonal antibody is the first therapeutic expansion for this patient population in over 10 years.

The app will deliver up-to-the-minute glucose data in patients using Freestyle Libre 2 glucose sensors.

It’s time to stop just recommending trigger avoidance strategies to patients. These are the proactive behaviors that will actually help improve migraine.

Researchers report antibody responses in kidney transplant recipients and the impact of specific regiments utilized by select patients.

Severe mental disorders had the highest odds ratios for the risk of mortality.

Previous research has shown that COVID-19 can impact ocular health.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

The FDA approved selexipag tablets for PAH in 2015.

Studies are needed to determine the best treatment regimen for these patients.

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

The FDA noted the extent of the treatment effect of tenapanor is of unclear clinical significance, despite evidence of efficacy.

The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.

Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.

Higher microbiome α diversity had an association with less T2D and lower insulin resistance in individuals without diabetes.